The company signed an agreement with Indorama Group to exit their joint venture company, Egyptian Indian Polyester Company (EIPET).

Following stocks are close to their 52-week low as at 12.43 p.m. on June 15, 2018.

Dr. Reddy's Laboratories has received final approval from the US drug regulator for launching Buprenorphine and Naloxone Sublingual Film in the US market. The product is being launched through an approved Risk Evaluation and Mitigation Strategy (REMS) Program.

The share price of pharma major Alembic Pharmaceuticals continued to surge in Friday’s trading session. The share price grew by 7 per cent on Friday as the company bagged EIR for its formulation facility at Panelav, Gujarat from the US Food and Drugs Association. 

The markets on June 15, 2018 opened gap down. BSE Sensex is trading at 35,555.79, down by 44.03 points and the Nifty is trading at 10,800.80, down by 7.25 points. 

The stock of Virinchi surged as the company announced the start of expansion work at Banjara Hills healthcare facilities in Hyderabad.

Overall volumes in futures & options currently stand at 1.41 crore contracts with a turnover of Rs. 14,18,956.96 crore.

Overall volumes in futures & options currently stand at 1.41 crore contracts with a turnover of Rs. 14,18,956.96 crore.

Going ahead, Thursday’s session low of 10,774 would be a crucial support level. However, a move below this level would open gates for further correction which may take the index up to the zone of 10,710-10,700, while on the upside, the level of 10,850 would act as an immediate resistance level, followed by 10,890. Stocks in news: Dr Reddy’s Laboratories, TNPL, Inox Leisure, Ruchi Soya Industries, Jyoth Laboratories, ICICI Bank, EKC and Wirpo.

Indian equities are poised to open on a cautious note tracking subdued leads from the Asian markets. Nifty 50 index futures on the Singapore stock exchange is currently trading with a loss of 18 points at 10,797.